• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.

作者信息

Das Gupta V, Gibbs C W, Ghanekar A G

出版信息

Am J Hosp Pharm. 1978 Nov;35(11):1382-5.

PMID:568384
Abstract

The stability of liquid dosage forms of ethacrynic acid (1 mg/ml), indomethacin (2 mg/ml), methyldopate hydrochloride (25 mg/ml), prednisone (0.5 mg/ml) and spironolactone (2 mg/ml), which often are compounded extemporaneously, was studied. One or two liquid dosage forms of each of the five drugs was prepared with the pure drug or the powder from a commercial dosage form using aqueous sorbitol or simple syrup alone or with a 10% (v/v) solution of alcohol in water. The dosage forms were stored at 24 C in amber-colored bottles for 21-224 days and assayed by various methods. All solutions studied were stable for at least 84 days. A solution was considered stable if it retained 90% of its drug concentration. Except for the prednisone solution, all solutions were stable for at least 164 days; however, the solution of methyldopate hydrochloride prepared from the pure drug became discolored after 98 days. The liquid dosage forms studied have limited stability but can be used by the pharmacist when extemporaneous oral solutions of these drugs are needed.

摘要

相似文献

1
Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
Am J Hosp Pharm. 1978 Nov;35(11):1382-5.
2
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.盐酸可乐定口服液的临时配制稳定性。
Am J Hosp Pharm. 1992 Jan;49(1):122-5.
3
Stability of extemporaneously compounded spironolactone suspensions.临时配制的螺内酯混悬液的稳定性。
Am J Hosp Pharm. 1989 Oct;46(10):2040-2.
4
Stability of an extemporaneously compounded baclofen oral liquid.巴氯芬临时配制口服液的稳定性。
Am J Hosp Pharm. 1993 Nov;50(11):2353-5.
5
Stability of famotidine in an extemporaneously prepared oral liquid.法莫替丁在临时配制口服液中的稳定性。
Am J Hosp Pharm. 1993 Apr;50(4):691-3.
6
Stability of isradipine in an extemporaneously compounded oral liquid.伊拉地平在临时配制口服液中的稳定性。
Am J Hosp Pharm. 1994 Oct 1;51(19):2409-11.
7
Stability of extemporaneously prepared rufinamide oral suspensions.临时制备的雷夫酰胺口服混悬液的稳定性。
Ann Pharmacother. 2010 Mar;44(3):462-5. doi: 10.1345/aph.1M647. Epub 2010 Feb 11.
8
Stability of extemporaneous suspensions of carbamazepine.
Am J Hosp Pharm. 1981 Dec;38(12):1929-31.
9
Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
Am J Hosp Pharm. 1992 Jul;49(7):1720-4.
10
Stability of an extemporaneously compounded terbutaline sulfate oral liquid.硫酸特布他林口服溶液的稳定性(临时配制)
Am J Hosp Pharm. 1991 Feb;48(2):293-5.

引用本文的文献

1
Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle.即用型口服混悬剂载体中常用活性药物成分的相容性
Pharmaceutics. 2023 Sep 26;15(10):2388. doi: 10.3390/pharmaceutics15102388.